146 reports of this reaction
3.2% of all MITOMYCIN reports
#3 most reported adverse reaction
DIARRHOEA is the #3 most commonly reported adverse reaction for MITOMYCIN, manufactured by UroGen Pharma, Inc.. There are 146 FDA adverse event reports linking MITOMYCIN to DIARRHOEA. This represents approximately 3.2% of all 4,566 adverse event reports for this drug.
Patients taking MITOMYCIN who experience diarrhoea should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DIARRHOEA is moderately reported among MITOMYCIN users, representing a notable but not dominant share of adverse events.
In addition to diarrhoea, the following adverse reactions have been reported for MITOMYCIN:
The following drugs have also been linked to diarrhoea in FDA adverse event reports:
DIARRHOEA has been reported as an adverse event in 146 FDA reports for MITOMYCIN. This does not prove causation, but indicates an association observed in post-market surveillance data.
DIARRHOEA accounts for approximately 3.2% of all adverse event reports for MITOMYCIN, making it one of the most commonly reported side effect.
If you experience diarrhoea while taking MITOMYCIN, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.